VIDEO: Investigating phenotypes of rheumatoid arthritis-associated interstitial lung disease
Click Here to Manage Email Alerts
SAN DIEGO — In this Healio video, Jeffrey A. Sparks, MD, MMSc, highlighted studies from members of his group at Brigham and Women’s Hospital that were presented at ACR Convergence 2023.
“Our group was lucky enough to have several presentations at ACR 2023,” said Sparks, an associate professor of medicine at Harvard Medical School and an associate program director of the Rheumatology Fellowship, director of Immuno-Oncology and Autoimmunity and director of the Joint Biology Consortium Human Biosamples Core at Brigham and Women’s Hospital.
The first presentation he spoke about was a large collaborative international study that stratified phenotypes of rheumatoid arthritis-associated interstitial lung disease (RA-ILD), while the second study investigated the tolerability and effectiveness of antifibrotics for the treatment of rheumatoid arthritis.
Sparks discussed one other presentation focused on RA-ILD that assessed the impact of sex, serostatus and smoking on different subtypes of RA-ILD.
Collapse
Juge PB, et al. Abstract 0774. Presented at: ACR Convergence 2023; Nov. 10-15, 2023; San Diego.
Juge PB, et al. Abstract 2479. Presented at: ACR Convergence 2023; Nov. 10-15, 2023; San Diego.
McDermott G, et al. Abstract 1279. Presented at: ACR Convergence 2023; Nov. 10-15, 2023; San Diego.
Click Here to Manage Email Alerts